Patents Assigned to Diurnal Limited
-
Publication number: 20230066665Abstract: We disclose a pharmaceutical composition adapted for oral delivery comprising native testosterone; a treatment regimen comprising administration of the composition(s); and methods and uses for the treatment of hormone related conditions such as hypogonadism in human male, female and transgender subjects.Type: ApplicationFiled: January 18, 2021Publication date: March 2, 2023Applicant: Diurnal LimitedInventors: Martin Whitaker, John Porter, Richard Ross, Stewart Jones, Elizabeth Cocks
-
Patent number: 10166194Abstract: The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression.Type: GrantFiled: July 5, 2017Date of Patent: January 1, 2019Assignee: Diurnal LimitedInventors: Hiep Huatan, Richard Ross, Martin Whitaker
-
Publication number: 20170296475Abstract: The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression.Type: ApplicationFiled: July 5, 2017Publication date: October 19, 2017Applicant: Diurnal LimitedInventors: Hiep Huatan, Richard Ross, Martin Whitaker
-
Patent number: 9750704Abstract: The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression.Type: GrantFiled: February 12, 2013Date of Patent: September 5, 2017Assignee: Diurnal LimitedInventors: Hiep Huatan, Richard Ross, Martin Whitaker
-
Patent number: 9717740Abstract: The disclosure relates to the treatment of adrenal insufficiency with particular but not limiting application to pediatric treatment regimens, the treatment of the elderly and non-human animals.Type: GrantFiled: March 30, 2017Date of Patent: August 1, 2017Assignee: Diurnal LimitedInventors: Hiep Huatan, Richard Ross, Martin Whitaker
-
Publication number: 20170202856Abstract: The disclosure relates to the treatment of adrenal insufficiency with particular but not limiting application to paediatric treatment regimens, the treatment of the elderly and non-human animals.Type: ApplicationFiled: March 30, 2017Publication date: July 20, 2017Applicant: Diurnal LimitedInventors: Hiep Huatan, Richard Ross, Martin Whitaker
-
Patent number: 9675559Abstract: The disclosure relates to the treatment of adrenal insufficiency with particular but not limiting application to pediatric treatment regimens, the treatment of the elderly and non-human animals.Type: GrantFiled: November 19, 2012Date of Patent: June 13, 2017Assignee: Diurnal LimitedInventors: Hiep Huatan, Richard Ross, Martin Whitaker
-
Patent number: 9649280Abstract: The disclosure relates to pharmaceutical compositions useful in the treatment of adrenal insufficiency in paediatric or elderly subjects.Type: GrantFiled: May 12, 2014Date of Patent: May 16, 2017Assignee: Diurnal LimitedInventors: Hiep Huatan, Richard Ross, Martin Whitaker, Norbert Poellinger, Annette Grave
-
Publication number: 20160081942Abstract: The disclosure relates to pharmaceutical compositions useful in the treatment of adrenal insufficiency in paediatric or elderly subjects.Type: ApplicationFiled: May 12, 2014Publication date: March 24, 2016Applicant: Diurnal LimitedInventors: Hiep Huatan, Richard Ross, Martin Whitaker, Norbert Poellinger, Annette Grave
-
Publication number: 20150133417Abstract: We describe lipid based pharmaceutical compositions adapted for oral delivery and optionally delivery in accordance with a circadian rhythm.Type: ApplicationFiled: January 21, 2015Publication date: May 14, 2015Applicant: Diurnal LimitedInventors: Hiep Huatan, Richard Ross
-
Patent number: 9012436Abstract: We describe lipid based pharmaceutical compositions adapted for oral delivery and optionally delivery in accordance with a circadian rhythm.Type: GrantFiled: April 27, 2009Date of Patent: April 21, 2015Assignee: Diurnal LimitedInventors: Hiep Huatan, Richard Ross
-
Publication number: 20140370113Abstract: The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression.Type: ApplicationFiled: February 12, 2013Publication date: December 18, 2014Applicant: Diurnal LimitedInventors: Hiep Huatan, Richard Ross, Martin Whitaker
-
Publication number: 20140287052Abstract: The disclosure relates to the treatment of adrenal insufficiency with particular but not limiting application to paediatric treatment regimens, the treatment of the elderly and non-human animals.Type: ApplicationFiled: November 19, 2012Publication date: September 25, 2014Applicant: Diurnal LimitedInventors: Hiep Huatan, Richard Ross, Martin Whitaker